Novo Nordisk Sues Pfizer Over Insulin Patent
Hoping to block its rival from getting a leg up in the lucrative insulin market, drug maker Novo Nordisk A/S has smacked Pfizer Inc. with an infringement suit, claiming that its...To view the full article, register now.
Already a subscriber? Click here to view full article